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this procedure in 39 patients, judged poor risks for standard
open TAAA repair, with 10 % mortality.
Author Disclosures: R. L. McCann: Terumo, Honorar-
ium.
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Incidence and Outcomes of TAG compression with
Comparison to the c-TAG
Karthikeshwar Kasirajan. Emory University, Atlanta, GA
Objectives: The present study was undertaken to
evaluate the incidence and outcomes of infolding with
the GORE TAG® Thoracic Endoprosthesis (TAG de-
vice) and to better understand the factors that might
help predict these events.
Methods: Infolding events reported to WL Gore
(Flagstaff, AZ) on or before December 2008 related to
graft failure following the use of the TAG device were
reviewed. When available, images were analyzed by an
independent core laboratory.
Results: Between 1998 and December 2008, device
infolding was reported in 139 cases (mean patient age
4017 years, 73.4%males) in a total of 33,289 TAG device
implants (0.4% incidence). The majority of events were
noted in implants for trauma (60%) and a 26 or 28mm
diameter device was used in 74% of the procedures. Ap-
proximately half of all patients (51%) were asymptomatic
with diagnosis being made on routine chest imaging. The
median time to diagnosis was 9.5 days (0 - 2190d). A total
of 124 patients received 136 interventions, including
30 (24%) open surgical conversions and a variety of endo-
vascular techniques (40% large balloon expandable stent(s),
31% relining with additional endograft). A total of 10
patients died following device infolding, all of which re-
ceived one or more interventions to attempt to repair the
infolded device. The newConformable GORETAG device
has been modified to prevent this event with 1400 im-
plants in Europe with 550 and 6-month follow-up with no
reports of compression.
Conclusions: TAG device infolding is an infrequent
event that occurs predominantly in young patients with
small aortic diameters and tight arch curvature. This
appears primarily related to excessive device oversizing
compounded by the high peak blood flow velocities of
young patients and a lack of inner curvature apposition.
The newer c-TAG in short-term follow up appears to have
overcome the compression events.
Author Disclosures: K. Kasirajan: WL Gore, Research
Grants.
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Contemporary Results of Open Complex Abdominal
Aortic Aneurysm Repair Using a Standardized Classi-
fication for Comparison with Fenestrated Endografts
Gustavo S. Oderich, Tiziano Tallarita, Manju Kalra, Audra
A. Duncan, Peter Gloviczki, Terri Vrtiska, Steve Cha,
Thomas C. Bower. Division of Vascular and Endovascular
Surgery, Mayo Clinic, Rochester, MN
Objectives: This study analyzed outcomes of open
repair of complex abdominal aortic aneurysms (cAAA)
based upon an anatomic and endovascular classification
system, thereby providing a standard of comparison for
fenestrated endovascular repair (FEVAR).
Methods: We reviewed outcomes of 461 patients who
underwent open cAAA repair (2000-2010). Pre-operative
digital imaging was analyzed by a blinded investigator using
centerline of flow to define aneurysm extent and the ex-
pected number of fenestrations that would be required to
provide 2-cm of proximal seal for FEVAR. End-points were
mortality, morbidity, renal function (RF) deterioration,
re-interventions, and patient survival.
Results: There were 354 male and 107 female patients
withmean age of 738 years. Operative mortality was 1.3%
(6/461). Any morbidity occurred in 260 patients (57%),
and was severe (SVS 3) in 91 (20%). Five-year patient
survival, freedom from re-intervention, and freedom from
RF deterioration were 723%, 902%, and 843%. In-
creasing level of aneurysm complexity (see table) was asso-
ciated with greater mortality, severe morbidity and dialysis
rates using either classification system (P0.001).
Conclusions: Open cAAA repair can be performed
safely with low mortality (1.3%) but high risk of complica-
tions. These data stratified by anatomic classification and
the expected number of fenestrations provide a benchmark
for comparison with results of FEVAR.













Juxtarenal 235 0 30 (13) 5 (2) 89  6 92  2 764
Suprarenal 175 2 (1.1) 38 (22) 9 (5) 82  5 88  4 69  5
Type IV TAAA 51 4 (7.8) 22 (43) 7 (14) 64  11 81  8 62  10
Expected Number of Fenestrations
One 7 0 0 0 75  21 100 67  3
Two 214 0 31 (14) 4 (2) 92  3 92  3 76  4
Three 118 1 (0.8) 20 (17) 7 (6) 72  8 90  5 63  7
Four 74 5 (6.7) 31 (42) 8 (11) 72  9 84  6 71  8
Total 461 6 (1.3) 91 (20) 21 (4.5) 84  3 90  2 72  3
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